Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of conditions with limited treatment options.
For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is on the horizon.
Please reach out to us using the form below.
Thank you for getting in touch! Someone from our team will respond shortly.